marketresearchtrends

  Daptomycin Market The Daptomycin Market is anticipated to grow at a robust CAGR of 3.90%. Therefore, the market value will further increase up to USD 3.90 Billion in the studied forecast period 2022-2030. Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria. The growth of the global daptomycin market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections. Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics , are also expected to fuel the market growth during the forecast period. However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the new agent are ex...

Daptomycin Market The Daptomycin Market is anticipated to grow at a robust CAGR of 3.90%. Therefore, the market value will further increase up to USD 3.90 Billion in the studied forecast period 2022-2030. Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces rose sports. Daptomycin is used for the treatment of various bacterial infections caused by gram-positive bacteria. The growth of the global daptomycin market can be attributed to the high demand of daptomycin due to rising infections in the bloodstream, and increasing complicated skin and skin structure infections. Furthermore, the rise of right-sided infective endocarditis, and daptomycin as an antibacterial drug, a bacterial metabolite and a member of calcium-dependent antibiotics, are also expected to fuel the market growth during the forecast period. However, increasing rates of infection with gram-positive bacteria and the rapid emergence of resistance to the new agent are expected ...